(DTIL) – PRNewswire
-
Atomwise Strengthens its Management Team, Adds Veteran Biopharma Leader David Thomson, Ph.D. as Chief Scientific Officer and Two Additional Senior Appointments
-
Artios Pharma Expands US Leadership Team with the Appointment of Abid Ansari as Chief Financial Officer
-
Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement
Back to DTIL Stock Lookup
